Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher’s disease

Table 1 General data

Patient	S-MRI	R-S-ELA grade	L-S-ELA grade	T-score	Z-score	ChT nmol/mL/h NR: 4.0–133.0	CCL18/PARC ng/mL NR: 12.0–165.0	Lyso Gb1 ng/mL NR: < 0.88	Hb g/dL	Ferritin ng/mL NR: 15–250
011	12	1	1	− 0.60	0.09	126	62	1.56	12.8	201
02	2	1	1	1.51	1.37	63	55	2.50	13.8	353
03	5	2	2	− 0.42	− 0.42	50	73	< 0.88	17.3	300
04	9	3	3	− 0.59	− 0.27	6575	553	39.57	15.5	114
05	11	3	2	− 1.95	− 1.66	1697	360	40.95	13.8	2000
06	2	1	1	− 0.80	0.39	96	76	1.50	14.0	93
07	0	2	2	1.07	1.45	377	99	3.10	13.8	553
08	0	2	1	− 0.61	− 0.71	394	86	6.50	13.8	353
09	15	3	1	− 2.43	− 1.47	208	150	50.32	14.1	29
10	6	1	2	− 2.50	− 1.8	5136	529	131.25	12.6	385
11	6	3	3	− 2.50	− 1.7	351	233	4.20	12.8	60
12	8	2	2	0.42	0.61	1368	239	15.10	15.5	360
13	4	1	1	− 2.64	− 1.59	1840	328	21.90	13.5	220
14	18	3	3	− 2.06	− 2.32	–	265	2.73	13.8	250
15	8	3	2	− 1.40	− 1.43	974	265	2.80	13.5	74
16	8	3	1	1.12	1.15	1849	474	57.90	13.3	700
17	4	1	1	− 1.49	− 0.59	337	76	5.10	12.2	65
18	11	2	1	− 0.60	− 1.54	2972	925	144.0	14.1	200
19	0	1	1	− 0.98	0.31	46	31	< 0.88	13.8	50
20	0	1	1	0.24	− 0.15	809	88	9.90	15.7	74
21	7	3	2	1.27	0.85	5740	526	124.6	13.0
22	12	1	1	− 2.29	− 1.96	1700	293	60.10	14.0	30
23	8	1	1	0.56	0.56	90	60	3.5	13.3	91
24	12	1	1	− 1.56	− 2.24	491	201	13.4	14.7	27
25	7	2	2	0.74	3.13	541	232	4.5	13.6	1733
26	13	2	1	0.76	2.2	1554	776	124.5	14.4	1349
27	4	1	1	− 0.21	− 0.68	108	53	< 0.88	13.5	350
Total	7.1 0–18			− 0.67 1.51; − 2.39		1480 50–6575	253 31–776	23.3 < 0.88–144		399.3 27–2000

S-MRI Spanish MRI score, R-S-ELA Achilles right strain-elastography, L-S-ELA Achilles left strain-elastography, ChT Chitotriosidase

ISSN: 1749-799X